Alan List - 18 Oct 2024 Form 3 Insider Report for Kintara Therapeutics, Inc. (HURA)

Role
Director
Signature
/s/ Dan Dearborn as Power of Attorney for Alan List
Issuer symbol
HURA
Transactions as of
18 Oct 2024
Net transactions value
$0
Form type
3
Filing time
22 Oct 2024, 20:38:51 UTC
Previous filing
03 May 2024
Next filing
06 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KTRA Common Stock 0 18 Oct 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3 is being filed solely to reflect the reporting person becoming a director, officer or 10% owner of TuHURA Biosciences, Inc.

Remarks:

See Exhibit 24 - Power of Attorney.